Asymmetric dimethylarginine is strongly associated with cognitive dysfunction and brain MR spectroscopic abnormalities in cirrhosis

Journal of Hepatology

Volumn 58, Issue 1, 2013, Pages 38-44

  Bajaj, Jasmohan S ^a   Ahluwalia, Vishwadeep ^a   Wade, James B ^a   Sanyal, Arun J ^a   White, Melanie B ^a   Noble, Nicole A ^a   Monteith, Pamela ^a   Fuchs, Michael ^a   Sterling, Richard K ^a   Luketic, Velimir ^a   Bouneva, Iliana ^a   Stravitz, Richard T ^a   Puri, Puneet ^a   Kraft, Kenneth A ^a   Gilles, Hochong ^a   Heuman, Douglas M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

ADMA; Hepatic encephalopathy; Pathogenesis; TIPS

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; N(G),N(G) DIMETHYLARGININE;

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; GRAY MATTER; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; SCORING SYSTEM; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; WHITE MATTER;

ADULT; ARGININE; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; GLUTAMIC ACID; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; INOSITOL; LIVER CIRRHOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84871236051     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.08.005     Document Type: Article

References (26)

1. T. Abe, H. Tohgi, T. Murata, C. Isobe, and C. Sato Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease Neurosci Lett 312 2001 177 179
2. J.S. Bajaj, J.B. Wade, and A.J. Sanyal Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy Hepatology 50 2009 2014 2021
3. V. Balasubramaniyan, G. Wright, V. Sharma, N.A. Davies, Y. Sharifi, and A. Habtesion Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats Am J Physiol Gastrointest Liver Physiol 302 2012 G145 G152
4. R.F. Butterworth Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 53 2011 1372 1376
5. M. Guevara, C. Bru, P. Gines, G. Fernandez-Esparrach, P. Sort, and R. Bataller Increased cerebrovascular resistance in cirrhotic patients with ascites Hepatology 28 1998 39 44
6. D. Haussinger, and F. Schliess Pathogenetic mechanisms of hepatic encephalopathy Gut 57 2008 1156 1165
7. R.D. Hawkins NO honey, I don't remember Neuron 16 1996 465 467
8. L.T. Huang, C.C. Chen, J.M. Sheen, Y.J. Chen, C.S. Hsieh, and Y.L. Tain The interaction between high ammonia diet and bile duct ligation in developing rats: assessment by spatial memory and asymmetric dimethylarginine Int J Dev Neurosci 28 2009 169 174
9. J.T. Kielstein, F. Donnerstag, S. Gasper, J. Menne, A. Kielstein, and J. Martens-Lobenhoffer ADMA increases arterial stiffness and decreases cerebral blood flow in humans Stroke 37 2006 2024 2029
10. E. Kosenko, Y. Kaminsky, A. Kaminsky, M. Valencia, L. Lee, and C. Hermenegildo Superoxide production and antioxidant enzymes in ammonia intoxication in rats Free Radic Res 27 1997 637 644
11. D.A. Langer, and V.H. Shah A gas, an amino acid, and an imposter: the story of nitric oxide, l-arginine, and ADMA in portal hypertension Hepatology 42 2005 1255 1257
12. P. Lluch, B. Torondel, P. Medina, G. Segarra, J.A. Del Olmo, and M.A. Serra Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis J Hepatol 41 2004 55 59
13. M.J. McPhail, N.R. Patel, and S.D. Taylor-Robinson Brain imaging and hepatic encephalopathy Clin Liver Dis 16 2012 57 72
14. G. Mehta, V. Sharma, A. Habtesion, V. Balasubramaniyan, N.A. Davies, and R. Jalan Gene delivery of dimethylarginine dimethylaminohydrolase-1 reduces portal pressure in bile duct-ligated rats (abstract) J Hepatol 56 Suppl. 2 2012 S52
15. C. Montoliu, O. Cauli, A. Urios, N. ElMlili, M.A. Serra, and R. Giner-Duran 3-Nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis Am J Gastroenterol 106 2011 1629 1637
16. M. Oria, J. Romero-Gimenez, J.A. Arranz, E. Riudor, N. Raguer, and J. Cordoba Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis J Hepatol 56 2012 109 114
17. M.C. Richir, R.H. Bouwman, T. Teerlink, M.P. Siroen, T.P. de Vries, and P.A. van Leeuwen The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function JPEN J Parenter Enteral Nutr 32 2008 613 621
18. R. Schnabel, S. Blankenberg, E. Lubos, K.J. Lackner, H.J. Rupprecht, and C. Espinola-Klein Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study Circ Res 97 2005 e53 e59
19. M.L. Selley Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease Neurobiol Aging 24 2003 903 907
20. D.L. Shawcross, G. Wright, S.W. Olde Damink, and R. Jalan Role of ammonia and inflammation in minimal hepatic encephalopathy Metab Brain Dis 22 2007 125 138
21. M.P. Siroen, R. Wiest, M.C. Richir, T. Teerlink, J.A. Rauwerda, and F.T. Drescher Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients World J Gastroenterol 14 2008 7214 7219
22. M.A. Smith, P.L. Richey Harris, L.M. Sayre, J.S. Beckman, and G. Perry Widespread peroxynitrite-mediated damage in Alzheimer's disease J Neurosci 17 1997 2653 2657
23. F. Vizzutti, R.G. Romanelli, U. Arena, L. Rega, M. Brogi, and C. Calabresi ADMA correlates with portal pressure in patients with compensated cirrhosis Eur J Clin Invest 37 2007 509 515
24. K. Weissenborn, J.C. Ennen, H. Schomerus, N. Ruckert, and H. Hecker Neuropsychological characterization of hepatic encephalopathy J Hepatol 34 2001 768 773
25. L.M. Ytrebo, R.G. Kristiansen, H. Maehre, O.M. Fuskevag, T. Kalstad, and A. Revhaug l-Ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure Hepatology 50 2009 165 174
26. O. Zafiris, G. Kircheis, H.A. Rood, F. Boers, D. Haussinger, and K. Zilles Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study Neuroimage 22 2004 541 552